47 statistical programming associate director jobs at 36 companies in United States
3mo
Save
Mark Applied
Hide
3mo
Associate Director, Statistical Programming
Redwood City, California, United States
$186k-$233k/yrOnsiteFull Time
Revolution MedicinesNASDAQ: RVMD: Clinical-stage oncology developing targeted RAS-addicted cancer therapies.
14+ YOE14+ years of Statistical Programming experience in exploratory-stage oncology trials; BS/BA; leadership of contractors; SAS programming experience.
MapLight TherapeuticsNasdaq Global Market: MPLT: Clinical-stage biopharmaceutical developing circuit-specific medicines for patients with central nervous system disorders.
8+ YOEMaster’s in statistics, computer science or related field; 8+ years statistical programming in pharma/biotech; SAS expert; CDISC SDTM/ADaM; CRO management; FDA/ICH knowledge.
PepGenNasdaq: PEPG: Clinical-stage biotechnology developing oligonucleotide therapies for severe neuromuscular and neurologic diseases.
8+ YOEBS/MS in a relevant field and 8+ years of pharmaceutical or biotechnology statistical programming experience. Expert SAS required; CDISC and regulatory submission knowledge required. CRO oversight experience required.
SAS, R, SDTM, ADaM, Tables, Listings, and Figures (TLFs), define.xml, Statistical Analysis Plan (SAP), Case Report Form (CRF)
Avenzo Therapeutics: Clinical-stage biotechnology developing next-generation oncology therapies for cancer patients.
6+ YOEHands-on SAS statistical programmer with CDISC experience to lead programming for clinical study protocols, oversee CRO programmers, deliver SDTM/ADaM datasets and TLFs, and ensure regulatory compliance (ICH/FDA/GCP).
Corcept TherapeuticsNasdaq Capital Market: CORT: Public biopharmaceutical developing and commercializing cortisol-modulating medicines for severe endocrine, cancer, metabolic, and neurologic disorders.
10+ YOE10+ years clinical trial statistical programming experience, deep SAS and CDISC SDTM/ADaM knowledge, Pinnacle 21 experience, submission readiness, MS preferred, strong communication and independent problem-solving skills.
SAS BASE, SAS MACRO, SAS STAT, SAS GRAPH, SAS ACCESS, CDISC SDTM, CDISC ADaM, Pinnacle 21, Spotfire, Tableau, RShiny
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, experience leading programming teams, CDISC (SDTM/ADaM) knowledge, proficiency in R and SAS, strong communication and organization.
AlkermesNasdaq: ALKS: Public Irish biopharmaceutical developing and commercializing neuroscience medicines for people with psychiatric and neurological disorders.
8+ YOEAdvanced degree preferred; 8+ years in pharma/biotech/CRO; SAS programming; CDISC SDTM/ADaM; GCP/ICH knowledge; strong project leadership.
SAS, SAS/STAT, SAS/GRAPH, SAS MACROS, BASE SAS, ADaM, CDISC, R, Python
Centessa PharmaceuticalsNASDAQ: CNTA: Lilly-owned clinical-stage biopharmaceutical developing orexin receptor 2 agonists for patients with sleep-wake disorders.
10+ YOEMaster's degree with 10+ years or bachelor's degree with 15+ years of SAS programming in pharmaceutical, biotech, or CRO settings; CDISC, SDTM, ADaM, regulatory, and leadership experience required.
Regeneron PharmaceuticalsNASDAQ: REGN: Biotechnology discovering and developing life-transforming medicines.
10+ YOEMaster's degree and 10+ years clinical programming experience; advanced SAS (Base, Stat, Macro, Graph); project and people management; therapeutic area and regulatory submission knowledge.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, CDISC SDTM/ADaM expertise, leadership experience, proficiency with R, strong communication and regulatory submission experience. Bachelor's required; Master's preferred.
Zenas BioPharmaNasdaq Global Select Market: ZBIO: Public clinical-stage biopharmaceutical developing and commercializing immunology therapies for patients with autoimmune diseases.
7+ YOEMaster's in Biostatistics/CS with 7+ years or Bachelor's with 9+ years; strong SAS and CDISC (SDTM/ADaM) knowledge; regulatory filing and ISS/ISE experience; CRO/vendor management and excellent communication.
Avalo TherapeuticsNasdaq Capital Market: AVTX: Public clinical-stage biotechnology developing IL-1β-based medicines for people with immune-mediated inflammatory diseases.
7+ YOE7+ years statistical programming experience (Sr Manager) or 9+ years (Associate Director) in biotech/pharma/CRO; advanced SAS proficiency, CDISC (SDTM/ADaM/Define.xml) expertise, experience with regulatory submissions, vendor/CRO oversight, and leadership/mentorship experience.
Harvard T.H. Chan School of Public Health: Nonprofit Harvard public health school educating leaders, conducting research, and developing solutions to improve population health and equity.
7+ YOERequires 7+ years of post-secondary education or relevant experience, supervisory experience, and extensive SAS expertise. Preferred: 7+ years of statistical programming, clinical research experience, and SAS, R, Bash, Linux, and Python skills.
SystImmune: US clinical-stage biopharmaceutical developing bispecific, multispecific antibodies and antibody-drug conjugates for cancer patients.
10+ YOE5+ MgmtBachelor's or master's degree in a numerate discipline; 10+ years in biostatistics or statistical programming in pharma/biotech; 5+ years leading teams; English and Chinese fluency; regulatory and CDISC expertise.
Rapport TherapeuticsNasdaq Global Market: RAPP: Public clinical-stage biopharmaceutical developing precision small-molecule medicines for neurological and psychiatric disorders.
8+ YOEBachelor's or master's degree in a quantitative or life science field; 8–10 years of biotech, pharmaceutical, or CRO statistical programming experience; expert SAS and CDISC expertise; team leadership and regulatory submission experience.
SAS, SAS Base, SAS Macro, SAS STAT, SAS GRAPH, CDISC, SDTM, ADaM, R, Python, eCTD, define.xml, cSDRG, ADRG
Associate Director, Statistical Programming - R Implementation
Basking Ridge, New Jersey, United States
$171k-$257k/yrOnsiteFull Time
Daiichi SankyoTokyo Stock Exchange: 4568: Global pharmaceutical advancing breakthrough therapies in oncology and medicine.
10+ YOEBachelor's degree in science or technology and 10+ years' experience, or master's degree and 7+ years. Requires R, SAS, CDISC SDTM/ADaM, clinical trials, statistics, and database expertise.
MBX BiosciencesNasdaq Global Select Market: MBX: Clinical-stage biopharmaceutical developing precision peptide therapies for patients with endocrine and metabolic disorders.
8+ YOERequires 8+ years of biotech or pharmaceutical statistical programming experience, advanced SAS proficiency, CDISC standards expertise, and CRO oversight; R and Python experience preferred.
SAS, Base SAS, SAS/Stat, SAS/Graph, SAS macros, ODS, R, Python, CDISC, SDTM, ADaM, define.xml, eSub, eCTD, SAPs, Case Report Forms (CRFs), Table, Listing, and Figure (TLF)
Neurocrine BiosciencesNasdaq Global Select Market: NBIX: Develops treatments for neurological, psychiatric, endocrine, and immunological disorders.
6+ YOERequires BS/BA with 10+ years, master's with 8+ years, or PhD with 6+ years in biopharmaceutical or CRO statistical programming, advanced SAS, managerial experience, CDISC knowledge, and leadership skills.
SAS, Microsoft Word, Microsoft Excel, Microsoft PowerPoint, SDTM, ADaM, CDISC